Showing results (441-450 of 537) with videos related to

Sort By:
Pageof 54
European Journal of Medicinal Chemistry|August 10, 2023
Structure activity relationships of 5-HT2B and 5-HT2C serotonin receptor antagonists: N6, C2 and 5'-Modified (N)-methanocarba-adenosine derivativesDilip K Tosh, Maggie M Calkins, Marko S Ivancich, et al.
Journal of Virology|March 1, 2003
T cells infiltrate the brain in murine and human transmissible spongiform encephalopathiesHanna Lewicki, Antoinette Tishon, Dirk Homann, et al.
Frontiers in Oncology|June 14, 2021
Tissue-Based Biomarkers for the Risk Stratification of Men With Clinically Localized Prostate CancerSpyridon P Basourakos, Michael Tzeng, Patrick J Lewicki, et al.
Urology Practice|March 12, 2026
Real-world experience with PSMA-PET in primary staging and biochemical recurrence settings: data from the Michigan Urological Surgery Improvement CollaborativePatrick Lewicki, Sabir Meah, Ana Moser, et al.
The Journal of Invasive Cardiology|November 16, 2016
Periprocedural Myocardial Injury After Recanalization of Single Chronic Coronary Occlusion - A Propensity Score Analysis Comparing Long-Term Clinical OutcomesMilosz Jaguszewski, Natasza Gilis-Malinowska, Juan Luis Gutierrez-Chico, et al.
Arthritis Care & Research|April 7, 2021
Impact of a Rheumatology Clinic Protocol on Tobacco Cessation Quit Line ReferralsChristie M Bartels, Lauren Johnson, Edmond Ramly, et al.
Prostate Cancer and Prostatic Diseases|July 26, 2022
Intensity of observation with active surveillance or watchful waiting in men with prostate cancer in the United StatesBashir Al Hussein Al Awamlh, Xian Wu, Daniel A Barocas, et al.
Autophagy|February 6, 2025
Development and validation of a sensitive sandwich ELISA against human PINK1Zahra Baninameh, Jens O Watzlawik, Bernardo A Bustillos, et al.
The Prostate|June 10, 2023
Prostate cancer genetic alterations in Hispanic menCamilo Arenas-Gallo, Stephen Rhodes, Jorge A Garcia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 7, 2012
Anti-DLL4 has broad spectrum activity in pancreatic cancer dependent on targeting DLL4-Notch signaling in both tumor and vasculature cellsWan-Ching Yen, Marcus M Fischer, Mark Hynes, et al.
Pageof 54